0
0 (0%)
Mosaic Immunoengineering Inc. [CPMV]
Source:
Company Overview
Mosaic Immunoengineering Inc is a development-stage biotechnology company focused on advancing and eventually commercializing immunotherapies for the treatment of cancer. We have historically advanced early-stage product candidates and we are pursuing new product candidates and platforms to build a product pipeline based on our deep understanding of immunotherapies.
| Country | United States |
| Headquarters | huntington beach, california |
| Phone Number | 657-208-0890 |
| Industry | manufacturing |
| CEO | Steven King |
| Website | www.mosaicie.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | |
| Operating Profit | $-0.9 |
| Net Income | $-0.9 |
| Net Cash | $-0 |
Profit Ratios
| Gross Margin | $0 |
| Operating Margin | |
| Profit as % of Revenues | |
| Profit as % of Assets | -574.2% |
| Profit as % of Stockholder Equity | 13.6% |
Management Effectiveness
| Return on Equity | 13.6% |
| Return on Assets | -651.1% |
| Turnover Ratio | |
| EBITA | $-0.9 |
Balance Sheet and Cash Flow Measures
| Total Assets | $0.1 |
| Total Liabilities | $6.9 |
| Operating Cash Flow | $-0.2 |
| Investing Cash Flow | $0 |
| Financing Cash Flow | $0.2 |
